EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-4327 targets TP53 to promote cervical cancer cell proliferation

Mei-Lin Chen, Chen-Yang Chu, Feng-Xian Zhang, Li-Pei Zhang, Ying Yang, Bai-Zhao Peng, Chuang-Hai Wu, Xiao-Mei Chen, Yan-Ting You, Bing-Ying Rong, Hiu Yee Kwan, Xiao-Shan Zhao und 1 weitere

Functional & Integrative Genomics · 2026-12 · 26 (1)

DOI: 10.1007/s10142-026-01934-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 11.07.2026. Verfasst von Mei-Lin Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Southern Medical University, No.1023, South Shatai Road, Baiyun District, Guangzhou, Guangdong, 510515, China. Hauptthemen laut MEDLINE: MicroRNAs, Uterine Cervical Neoplasms, Tumor Suppressor Protein p53. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is a leading cause of female malignancy worldwide. While microRNA-4327 (miR-4327) has been implicated as a potential oncogene, its functional role and molecular mechanisms in cervical cancer pathogenesis remain unclear. This study aimed to determine the oncogenic function of miR-4327 and elucidate its downstream regulatory mechanism in cervical cancer pathogenesis. We measured miR-4327 expression in clinical cervical cancer tissues and cell lines using quantitative real-time PCR (qRT-PCR). We then assessed its effects on proliferation, migration, invasion, and cell cycle progression through functional assays including cell counting kit-8 (CCK-8), colony formation, transwell, and flow cytometry. To evaluate tumor growth in vivo, we established a xenograft model in non-obese diabetic (NOD)-severe combined immune-deficient (scid) mice. Using bioinformatic analysis and luciferase reporter assays, we identified TP53 as a direct target of miR-4327 and further validated this regulatory relationship with gain- and loss-of-function experiments. We found that miR-4327 was significantly upregulated in cervical cancer and promoted malignant phenotypes such as proliferation, migration, invasion, and cell cycle progression in vitro. Consistent with this, overexpression of miR-4327 accelerated tumor growth in vivo. Mechanistically, we confirmed TP53 as a direct functional target of miR-4327. Knocking down TP53 phenocopied the oncogenic effects of miR-4327, while restoring TP53 expression rescued the tumor-promoting effects mediated by miR-4327. These findings reveal a novel miR-4327/TP53 regulatory axis and nominate miR-4327 as a potential therapeutic target for intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsUterine Cervical NeoplasmsTumor Suppressor Protein p53FemaleHumansCell ProliferationAnimalsMiceGene Expression Regulation, NeoplasticCell Line, TumorCell MovementMice, SCIDMice, Inbred NOD

Stichwörter der Autor:innen

Cell cycleCervical cancerMiR-4327ProliferationTP53

Substanzen

MicroRNAsTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Southern Medical University, No.1023, South Shatai Road, Baiyun District, Guangzhou, Guangdong, 510515, China.
  • School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, 999077, China.
  • School of Traditional Chinese Medicine, Southern Medical University, No.1023, South Shatai Road, Baiyun District, Guangzhou, Guangdong, 510515, China. zhaoxs@smu.edu.cn.
  • Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Guangzhou, 510515, China. zhaoxs@smu.edu.cn.
  • School of Traditional Chinese Medicine, Southern Medical University, No.1023, South Shatai Road, Baiyun District, Guangzhou, Guangdong, 510515, China. lyyxi@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, M. L., Chu, C. Y., Zhang, F. X., Zhang, L. P., Yang, Y., Peng, B. Z., Wu, C. H., Chen, X. M., You, Y. T., Rong, B. Y., Kwan, H. Y., Zhao, X. S., & Liu, Y. Y. (2026). MiR-4327 targets TP53 to promote cervical cancer cell proliferation. Functional & Integrative Genomics, 26(1). https://doi.org/10.1007/s10142-026-01934-9

Vancouver

Chen ML, Chu CY, Zhang FX, Zhang LP, Yang Y, Peng BZ, et al. MiR-4327 targets TP53 to promote cervical cancer cell proliferation. Functional & Integrative Genomics. 2026;26(1). doi:10.1007/s10142-026-01934-9

BibTeX
@article{Chen2026,
  author = {Chen, Mei-Lin and Chu, Chen-Yang and Zhang, Feng-Xian and Zhang, Li-Pei and Yang, Ying and Peng, Bai-Zhao and Wu, Chuang-Hai and Chen, Xiao-Mei and You, Yan-Ting and Rong, Bing-Ying and Kwan, Hiu Yee and Zhao, Xiao-Shan and Liu, Yan-Yan},
  title = {MiR-4327 targets TP53 to promote cervical cancer cell proliferation},
  journal = {Functional & Integrative Genomics},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1007/s10142-026-01934-9}
}
Kostenlos starten →